Litcius/Paper detail

Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial

Tomoko Yamazaki, Andrew J. Gunderson, Miranda Gilchrist, Mark H. Whiteford, Maria X Kiely, Amanda V. Hayman, David O’Brien, Rehan Ahmad, Jeffrey V. Manchio, Nathaniel Fox, Kayla McCarty, Michaela Phillips, Evelyn Brosnan, Gina M. Vaccaro, Rui Li, M. Simon, Eric Bernstein, Mary McCormick, Lena Yamasaki, Yaping Wu, Ashley Drokin, Trevor Carnahan, Yy To, William L. Redmond, Brian Lee, Jeannie Louie, Eric K. Hansen, Matthew C. Solhjem, Julie Cramer, Walter J. Urba, Michael J. Gough, Marka R. Crittenden, Kristina H. Young

2022The Lancet Oncology142 citationsDOI

Topics & Concepts

MedicineCapecitabineChemoradiotherapyOxaliplatinColorectal cancerRadiation therapyFluorouracilInternal medicinePhases of clinical researchGastroenterologyOncologyCancerSurgeryClinical trialColorectal Cancer Surgical TreatmentsColorectal Cancer Treatments and StudiesTGF-β signaling in diseases